Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Trial started last Sept.
http://www.hepatitiscnewdrugresearch.com/simeprevir-tmc435-and-tmc647055.html
This is very good news, I think. Great news. It opens up the Simeprevir-Sofosbuvir off-label possibilities that we've talked about.
And this filing has come a lot earlier than I thought...I was expecting a filing late in the year for Simeprevir.
Sofosbuvir and Simeprevir gets you close to 100% success with genotype 1...and now that's a possibility early next year, if you can find a doctor to do it and insurance to pay for it (and assuming Sofosbuvir is marketed quickly after approval).
No sure thing, but it looks like there will be an opportunity.
Off-label, here I come - oh, but I need my insurance to pay for it. It's possible!
We were talking about Simeprevir/Sofosbuvir earlier this month as a great new possibility.
The only things that weren't clear were whether Simeprevir would be filed for approval soon, whether docs/insurance companies would go for the off-label angle, and whether Gilead would be obnoxious and hold back Sofosbuvir til their combo was ready.
Now I tend to think Sofosbuvir will be released soon after approval, and now we know that Simeprevir has been filed...earlier than expected, to my mind.
The doctors might be hard to convince about this
But this still makes me very hopeful...
http://www.hivandhepatitis.com/hcv-treatment/experimental-hcv-drugs/4024-croi-2013-simeprevir-sofosbuvir-demonstrates-good-early-cure-rate-with-or-without-ribavirin
And Kcaseytn, I don't know my IL28B. They haven't checked that yet.
I know certain markers are more difficult...